JODID

This brand name is authorized in Austria, Germany, Poland, Romania, Turkey

Active ingredients

The drug JODID contains one active pharmaceutical ingredient (API):

1 Potassium iodide
UNII 1C4QK22F9J - POTASSIUM IODIDE

Potassium iodide is indicated as a thyroid-blocking agent to prevent the uptake of radioactive iodine, for example after a nuclear accident or during a nuclear medicine investigation before administering a radioiodinated compound, which is metabolised to iodide or which contains radioiodine impurities.

Read about Potassium iodide

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code Group title Classification
H03CA Iodine therapy H Systemic hormonal preparations, excl. Sex hormones and insulins → H03 Thyroid therapy → H03C Iodine therapy
Discover more medicines within H03CA

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
Country: DE Bundesinstitut für Arzneimittel und Medizinprodukte Identifier(s): 02545005, 03105998, 03106130, 03799133, 03942955, 03943676, 04619133, 04619156, 04620001, 04620018
Country: PL Rejestru Produktów Leczniczych Identifier(s): 100032570, 100201617
Country: RO Agenția Națională a Medicamentului și a Dispozitivelor Medicale Identifier(s): W66151003, W66151004
Country: TR İlaç ve Tıbbi Cihaz Kurumu Identifier(s): 8699808010117, 8699808010124

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.